Company intelligence / Profile preview

Diam

Plantation, Florida, United States

Ownership: Private
Employees: ~10
Development stage: Other

Overview

DiaM Life is a private digital health company focused on diabetes support and care navigation. The company operates a social health and care platform designed for people with diabetes, caregivers, and healthcare providers, combining community features with behavior science and artificial intelligence to improve self-management, education, engagement, and outcomes. Its offering appears to be a commercially available digital platform rather than a therapeutic drug pipeline. DiaM Life’s positioning is in connected diabetes care, patient support, and digital health enablement across multiple diabetes subtypes and prediabetes.

Therapeutic areas: Endocrinology
Modalities: Non-pharmacological therapySoftware
Industry: Digital Health Medical Devices

Beyond the preview

Go deeper on Diam.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Diam.

Explore the full profile